TCBPTC BioPharm (Holdings) plc

Nasdaq tcbiopharm.com


$ 4.42 $ -0.36 (-7.71 %)    

Tuesday, 20-Aug-2024 14:57:10 EDT
QQQ $ 482.88 $ 2.24 (0.47 %)
DIA $ 408.91 $ 0.43 (0.11 %)
SPY $ 560.81 $ 1.92 (0.34 %)
TLT $ 98.72 $ 0.06 (0.06 %)
GLD $ 232.16 $ -0.31 (-0.13 %)
$ 4.31
$ 4.31 x 100
-- x --
-- - --
$ 2.11 - $ 1,289.80
17,712
na
12.99M
$ -16,376.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 tc-biopharm-closes-public-offering-of-2m-adss-and-series-g-warrants-at-1-per-ads

Warrants Priced At £0.78 Per ADS, Expiring In One Year

 why-tc-biopharm-tcbp-stock-is-down-40

TC BioPharm shares are trading lower by 44% Wednesday morning. The company announced the pricing of an offering of 2 million un...

 tc-biopharm-has-been-granted-european-patent-number-ep3283620-titled-modified-gamma-delta-cells-and-uses-thereof-for-the-treatment-of-cancer-or-infectious-diseases

https://register.epo.org/application?number=EP16721208 

 tcbp-launches-compassionate-use-program-for-tcb008

The Company's lead therapeutic will be available through a newly opened compassionate use programEDINBURGH, Scotland, May 1...

 tc-biopharm-announces-exercise-of-warrants-for-31-million-gross-proceeds

TC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ:TCBP), a clinical stage biotechnology compa...

Core News & Articles
Market-Moving News for May 6th
05/06/2024 12:44:41

EYPT: -42% | EyePoint Pharmaceuticals shares are trading lower after the company's Phase 2 PAVIA trial of DURAVYU did not m...

 tc-biopharm-announces-execution-of-second-non-binding-loi-for-acquisition-targeting-innovative-car-t-therapies-financial-terms-not-disclosed

Acquisition target has established proof of concept data demonstrating the therapeutic potential for the treatment of multiple ...

 why-reliance-global-group-shares-are-trading-lower-by-around-11-here-are-20-stocks-moving-premarket

Shares of Reliance Global Group, Inc. (NASDAQ: RELI) fell sharply in today’s pre-market trading after reporting financial res...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION